Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Digital Health Acquisition Corp. Market Cap
The Digital Health Acquisition Corp. (DHAC) share price is expected to decrease by 100% over the next year. This is based on calculating the average 12-month share price estimate provided by 0 stock analysts who have covered DHAC. Price targets range from $ at the low end to $ at the high end. The current analyst consensus for DHAC is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
About 0 Wall Street analysts have assignedDHAC 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Digital Health Acquisition Corp. to sell. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on DHAC. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of DHAC.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
Data Not Found! | ||||
When did it IPO
2021
Staff Count
0
Country
United States
Sector/Industry
Financial Services/Shell Companies
CEO
Dr. Scott J. Wolf M.D.
Market Cap
$43.6M
In 2023, DHAC generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that DHAC's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Mon, 24 Jun 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - Digital Health Acquisition Corp. has completed its merger with VSee Lab, Inc. and iDoc Virtual Telehealth Solutions, and is now renamed VSee Health, Inc. Trading under this new name begins immediately.
Why It Matters - The merger of DHAC with VSee Lab and iDoc enhances VSee Health's market position in digital health, potentially driving growth and attracting investor interest in the telehealth sector.
Fri, 27 Oct 2023
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - Digital Health Acquisition Corp. will transfer its listing from the Nasdaq Global Market to the Nasdaq Capital Market, effective October 30, 2023. Trading symbols remain unchanged.
Why It Matters - The transfer to the Nasdaq Capital Market may indicate potential financial challenges for Digital Health, impacting investor confidence and stock valuation.
Mon, 08 May 2023
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - Digital Health Acquisition Corp. (NASDAQ: DHAC) extended its deadline for completing a business combination to August 8, 2023, after depositing a $350,000 fee into its trust account.
Why It Matters - The extension allows Digital Health Acquisition Corp. more time to find a merger target, potentially increasing the likelihood of a successful business combination and impacting investor confidence and stock performance.
Mon, 10 Oct 2022
Sentiment - NEUTRAL
Source - Accesswire
Summary - Digital Health Acquisition Corp. filed a proxy statement to hold a special stockholder meeting on October 20, 2022, to vote on extending the deadline for its business combination to February 8, 2023.
Why It Matters - The extension proposal allows Digital Health Acquisition Corp. more time to secure a business combination, impacting liquidity and potential future valuations, which could influence investor confidence and stock performance.
Thu, 16 Jun 2022
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - A publicly listed entity plans to enhance VSee's and iDoc's market reach and commercial capabilities, aiming to capture various synergies.
Why It Matters - Expansion of VSee and iDoc indicates potential revenue growth and market share increase, enhancing overall company valuation and attractiveness to investors.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
